Publicaciones en las que colabora con Miguel Pericacho Bustos (15)

2022

  1. Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models

    Frontiers in Medicine, Vol. 9

2021

  1. Pregnancy-induced high plasma levels of soluble endoglin in mice lead to preeclampsia symptoms and placental abnormalities

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-20

2020

  1. Angiogenesis in cardiopulmonary dirofilariosis: Does the Wolbachia surface protein have a pro-or anti-angiogenic effect?

    Journal of Helminthology

  2. Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis

    Angiogenesis, Vol. 23, Núm. 2, pp. 231-247

2017

  1. Circulating soluble endoglin modifies the inflammatory response in mice

    PLoS ONE, Vol. 12, Núm. 11

2013

  1. Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia

    PLoS ONE, Vol. 8, Núm. 1

  2. Endoglin Haploinsufficiency Promotes Fibroblast Accumulation during Wound Healing through Akt Activation

    PLoS ONE, Vol. 8, Núm. 1

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  2. L- and S-endoglin differentially modulate TGFβ1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts

    Journal of Cell Science, Vol. 121, Núm. 6, pp. 913-919

  3. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 11, pp. 3403-3411

2007

  1. Erratum: Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia (Human Molecular Genetics (2007) vol. 16 (13) (1515-1533) 10.1093/hmg/ddm069)

    Human Molecular Genetics

  2. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia

    Human Molecular Genetics, Vol. 16, Núm. 13, pp. 1515-1533

  3. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients

    Cancer Letters, Vol. 255, Núm. 1, pp. 71-76

2006

  1. Endoglin regulates cyclooxygenase-2 expression and activity

    Circulation Research, Vol. 99, Núm. 3, pp. 248-256

  2. Reduced angiogenic responses in adult endoglin heterozygous mice

    Cardiovascular Research, Vol. 69, Núm. 4, pp. 845-854